Publications by authors named "Eric D Labonte"

Claim this Profile
D
Discovery of Tenapanor: A First-in-Class Minimally Systemic Inhibitor of Intestinal Na/H Exchanger Isoform 3.
Jeffrey W Jacobs, Michael R Leadbetter, Noah Bell, Samantha Koo-McCoy, Christopher W Carreras

ACS Med Chem Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and Healthy Volunteer Studies of Potential Drug-Drug Interactions Between Tenapanor and Phosphate Binders.
Susanne Johansson, Maria Leonsson-Zachrisson, Mikael Knutsson, Andrew G Spencer, Eric D Labonté

Clin Pharmacol Drug Dev· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal Inhibition of Sodium-Hydrogen Exchanger 3 Reduces Phosphorus Absorption and Protects against Vascular Calcification in CKD.
Eric D Labonté, Christopher W Carreras, Michael R Leadbetter, Kenji Kozuka, Jill Kohler

J Am Soc Nephrol· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intestinal inhibition of the Na+/H+ exchanger 3 prevents cardiorenal damage in rats and inhibits Na+ uptake in humans.
Andrew G Spencer, Eric D Labonte, David P Rosenbaum, Craig F Plato, Christopher W Carreras

Sci Transl Med· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postprandial lysophospholipid suppresses hepatic fatty acid oxidation: the molecular link between group 1B phospholipase A2 and diet-induced obesity.
Eric D Labonté, Paul T Pfluger, James G Cash, David G Kuhel, Juan C Roja

FASEB J· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice.
Eric D Labonté, Lisa M Camarota, Juan C Rojas, Ronald J Jandacek, Dean E Gilham

Am J Physiol Gastrointest Liver Physiol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and physiological regulation of intestinal lipid absorption. III. Intestinal transporters and cholesterol absorption.
David Y Hui, Eric D Labonté, Philip N Howles

Am J Physiol Gastrointest Liver Physiol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Class B type I scavenger receptor is responsible for the high affinity cholesterol binding activity of intestinal brush border membrane vesicles.
Eric D Labonté, Philip N Howles, Norman A Granholm, Juan C Rojas, Joanna P Davies

Biochim Biophys Acta· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carboxyl ester lipase deficiency exacerbates dietary lipid absorption abnormalities and resistance to diet-induced obesity in pancreatic triglyceride lipase knockout mice.
Dean Gilham, Eric D Labonté, Juan C Rojas, Ronald J Jandacek, Philip N Howles

J Biol Chem· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Group 1B phospholipase A2-mediated lysophospholipid absorption directly contributes to postprandial hyperglycemia.
Eric D Labonté, R Jason Kirby, Nicholas M Schildmeyer, April M Cannon, Kevin W Huggins

Diabetes· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relative ligand binding preference of the murine ileal lipid binding protein.
Eric D Labonté, Qianqian Li, Cyril M Kay, Luis B Agellon

Protein Expr Purif· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis